Your browser doesn't support javascript.
loading
Gamma-delta T-cell large granular lymphocytic leukemia in the setting of rheumatologic diseases.
Gorodetskiy, Vadim; Sidorova, Yulia; Biderman, Bella; Kupryshina, Natalia; Ryzhikova, Natalya; Sudarikov, Andrey.
Afiliación
  • Gorodetskiy V; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia.
  • Sidorova Y; Laboratory of Molecular Hematology, National Medical Research Center for Hematology, Moscow, Russia.
  • Biderman B; Laboratory of Molecular Hematology, National Medical Research Center for Hematology, Moscow, Russia.
  • Kupryshina N; Hematopoiesis Immunology Laboratory, Russian Cancer Research Center N.N. Blokhin, Moscow, Russia.
  • Ryzhikova N; Laboratory of Molecular Hematology, National Medical Research Center for Hematology, Moscow, Russia.
  • Sudarikov A; Laboratory of Molecular Hematology, National Medical Research Center for Hematology, Moscow, Russia.
Front Cell Dev Biol ; 12: 1434676, 2024.
Article en En | MEDLINE | ID: mdl-39161592
ABSTRACT

Background:

T-cell leukemia originating from large granular lymphocytes (T-LGL leukemia) is a rare lymphoid neoplasia characterized by clonal proliferation of large granular T lymphocytes expressing αß or γδ T-cell receptor (TCR) on the cell membrane. γδT-LGL leukemia, accounting for approximately 17% of all T-LGL leukemia cases, is associated with autoimmune diseases. However, the features of γδT-LGL leukemia in patients with rheumatologic diseases are still insufficiently characterized.

Methods:

In this retrospective study, 15 patients with rheumatologic disease-associated γδT-LGL leukemia were included. The patients were obtained from a single center from 2008 to 2023. Data related to clinical characteristics and rheumatologic diagnoses were collected. Immunophenotype evaluations as well as T-lymphocyte clonality (based on TCR-γ, TCR-ß, and TCR-δ gene rearrangements), and signal transducer and activator of transcription (STAT) three and STAT5B mutation analyses (by next-generation sequencing) were performed on blood, bone marrow, and spleen samples.

Results:

All but one patient had rheumatoid arthritis (RA). In 36% of patients, manifestations of γδT-LGL leukemia were present before or concurrently with clinical manifestations of RA. Splenomegaly was observed in 60% of patients and neutropenia (<1.5 × 109/L) was detected in 93% of cases. CD4-/CD8- and CD4-/CD8+ subtypes were detected in seven cases each. Mutations in STAT3 were detected in 80% of patients; however, STAT5B mutations were not detected. Evaluations of T-cell clonality and variant allele frequencies at STAT3 in the blood, bone marrow, and spleen tissue revealed an unusual variant of CD4-/CD8- γδT-LGL leukemia with predominant involvement of the spleen, involvement of the bone marrow to a less extent, and no tumor cells in peripheral blood.

Conclusion:

The mechanism by which γδT-LGL leukemia may induce the development of RA in some patients requires further investigation. Cases of RA-associated γδT-LGL leukemia with neutropenia and splenomegaly but no detectable tumor-associated lymphocytes in peripheral blood (the so-called splenic variant of T-LGL leukemia) are difficult to diagnose and may be misdiagnosed as Felty syndrome or hepatosplenic T-cell lymphoma.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2024 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2024 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Suiza